Biological phenotypes associated with individuals at high risk for developing alcohol-related disorders: Part 1

Addiction Biology

Volumn 5, Issue 1, 2000, Pages 5-22

  Hill, Shirley Y ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Dept of Psychiat Psychol/Hum G   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; BIOLOGICAL MARKER; DOPAMINE 2 RECEPTOR; NALOXONE; NALTREXONE; NEUROTRANSMITTER; OPIATE; OPIATE ANTAGONIST; SEROTONIN RECEPTOR;

ADDICTION; ADOLESCENT; ADULT; ALCOHOLISM; AMPLITUDE MODULATION; BRAIN NERVE CELL; CHILD; CLONE; DISEASE SEVERITY; ELECTRIC POTENTIAL; FAMILY STUDY; FEMALE; GENETIC LINKAGE; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MALE; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; REVIEW;

EID: 0033977463     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210071234     Document Type: Review

References (155)

1. 1. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 1995;52:374-83.
2. 2. Yuan H, Marazita M, Hill SY. Segregation analysis of alcoholism in high density families: a replication. Am J Med Genet: Neuropsychiatr Genet 1996;67:71-6.
3. 3. Hill SY, Steinhauer SR, Zubin J. Biological markers for alcoholism: a vulnerability model conceptualization. In: Rivers PC, editor. Alcohol and addictive behavior (Nebraska Symposium on Motivation, 1986). Lincoln and London: University of Nebraska Press; 1987, pp. 207-56.
4. 4. Hill SY, Neiswanger K. The value of narrow psychiatric phenotypes and supernormal controls. In: Blum K, Noble E, editors. Handbook of psychiatric genetics. Boca Raton: CRC Press, Inc.; 1997, pp. 37-46.
5. 5. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516-17.
6. 6. Scott WK, Pericak-Vance MA, Haines JL. Genetic analysis of complex diseases. Science 1997;275: 1327.
7. 7. Hill SY. Alternative strategies for uncovering genes contributing to alcoholism risk: unpredictable findings in a genetic wonderland. Alcohol 1998;16:53-9.
8. 8. Gu C, Todorov A, Rao DC. Combining extremely concordant sibpairs with extremely discordant sibpairs provides a cost effective way to linkage analysis of quantitative trait loci. Genet Epidemiol 1996;13:513-33.
9. 9. Reid LD, Hubbell CL. Opioids modulate rats' propensities to take alcoholic beverages. In: Naranjo CA, Sellers EM, editors. Novel pharmacological interventions for alcoholism. New York: Springer-Verlag; 1990, pp. 121-134.
10. 10. Hyytia P, Sinclair JD. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats. Alcohol Clin Exp Res 1993;17:631-6.
11. 11. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49: 876-80.
12. 12. Khachaturian H, Lewis ME, Schafer MKH, Watson SJ. Anatomy of the CNS opioid systems. Trends Neurosci 1985;8:111-19.
13. 13. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 1991;103:467-72.
14. 14. Hyytia P. Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 1993;45:697-701.
15. 15. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D. μopioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 1997;2: 490-4.
16. 16. Berrettini WH, Hoehe MR, Ferraro TN, De Maria PA, Gottheil E. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 1997;2:303-8.
17. 17. Hill SY, Zezza N, Wipprecht G. The mu receptor and risk for alcoholism. (Unpublished).
18. 18. Le AD, Tomkins DM, Sellers EM. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data. Alcohol Alcohol 1996; 31:27-32.
19. 19. Le Marquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol Psychiatry 1994;36:326-37.
20. 20. Insel TR, Zohar J, Benkelfat C, Murphy DL. Serotonin in obsessions, compulsions, and the control of aggressive impulses. Ann NY Acad Sci 1990;600:574-86.
21. 21. BrewertonT, Flament M, Rapoport J, Murphy D. Seasonal effects on platelet 5-HT content in patients with OCD and controls. Arch Gen Psychiatry 1993;50:409.
22. 22. Charney DS, Woods SW, Krystal JH, Heninger GR. Serotonin function and human anxiety disorders. Ann NY Acad Sci 1990;600: 558-73.
23. 23. Meltzer HY. Role of serotonin in depression. Ann NY Acad Sci 1990;600:486-500.
24. 24. Halmi KA. Basic biological overview of eating disorders. In: Bloom FE, Kuplev DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995, pp. 1609-16.
25. 25. Jimerson DC, Leseem MD, Hegg AP, Brewerton TD. Serotonin in human eating disorders. Ann NY Acad Sci 1990;600:532-44.
26. 26. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 1983;33:2609-14.
27. 27. Mann JJ, Arango V, Underwood MD. Serotonin and suicidal behavior. Ann NY Acad Sci 1990; 600:476-85.
28. 28. Lucas J, Hen R. New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci 1995;16:246-52.
29. 29. Peroutka SJ. Molecular biology of serotonin (5-HT) Receptors. Synapse 1994;18:241-60.
30. 30. Brett PM, Curtis D, Robertson MM, Gurling HM. Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Am J Psychiatry 1995; 152: 437-40.
31. 31. Curtis D, Sherrington R, Brett P, et al. Genetic linkage analysis of manic depression in Iceland. J R Soc Med 1993;86:506-10.
32. 32. Goldman D. Candidate genes in alcoholism. Clin Neurosci 1995;3:174-81.
33. 33. Kunovac JL, Stahl SM. Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am 1995;18:895-909.
34. 1B serotonin receptors. Nat Genet 1996;14 :98-101.
35. 1B receptor knock out-behavioral consequences. Behav Brain Res 1995;73:305-12.
36. 1Dβ) not linked to schizophrenia in five Canadian pedigrees. Hum Hered 1993;43:315-18.
37. 37. D. Goldman, personal communication.
38. 38. Hill SY. 5HT 1DB genotypes in alcoholics and their family members (unpublished).
39. 39. Ozaki N, Rosenthan N, Pesonen U et al. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls. Biol Psychiatry 1996;40:1267-72.
40. 40. Zhang HY, Ishigaki T, Tani K et al. Serotonin2A receptor gene polymorphism in mood disorders. Biol Psychiatry 1997;41:768-73.
41. 41. Arranz MJ, Erdmann J, Kirov G et al. 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Neurosci Lett 1997;224:95-8.
42. 42. Verga M, Macciardi F, Cohen S, Pedrini S, Smeraldi E. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am J Med Genet 1997;74: 21-5.
43. 43. Inayama Y, Yoneda H, Sakai T et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 1996;67:103-5.
44. 44. Pandey S, Lumeng L, Li T. Serotonin2C receptors and serotonin2C receptor-mediated phosphoinositide hydrolysis in the brain of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res 1996;20:1038-42.
45. 45. George D, Benkelfat C, Rawlings R et al. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 1997;154:81-7.
46. 3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology 1993;112:S68-75.
47. 3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur J Pharmacol 1987;138: 303-5.
48. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res 1990; 513:156-60.
49. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 1991;543:354-7.
50. 50. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987;94: 469-92.
51. 3 receptors in drug dependence. Drug Alcohol Depend 1995;38: 155-71.
52. 3 receptor blockade: a preliminary study in healthy male volunteers. Psychopharmacology 1993;112: 142-4.
53. 3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 1994;18: 879-85.
54. 54. Ramamoorthy S, Bauman AL, Moore KR et al. Antidepressant-and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993;90:2542-6.
55. 55. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 1993;91:67-72.
56. 56. Lesch KP, Balling U, Gross J et al. Organization of the human serotonin transporter gene. J Neural Transm 1994;95:157-62.
57. 57. Lesch KP, Gross J, Franzek F, Wolozin BL, Riederer P, Murphy DL. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 1995;37: 215-23.
58. 58. Ogilvie AD, Battersby S, Bubb VJ et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996;347:731-3.
59. 59. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31.
60. 60. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992;13:177-93.
61. 61. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapor. Alcohol Alcohol 1991;26:129-37.
62. 62. Volicer L, Biagioni TM. Effect of ethanol administration and withdrawal on GABA receptor binding in rat cerebral cortex. Subst Alcohol Actions/ Misuse 1982;3:31-9.
63. 63. Buck KJ, Metten P, Belknap JK, Crabbe JC. Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice. J Neurosci 1997;17:3946-55.
64. α6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry 1999;45: 647-51.
65. 65. Hodge CW, Haraguchi M, Samson HH. Microinjections of dopamine agonists in nucleus accumbens increase ethanol reinforced responding. Pharmacol Biochem Behav 1992;43: 249-54.
66. 66. Hodge CW, Samson HH, Tolliver GA, Haraguchi M. Effects of intraaccumbens injections of dopamine agonists and antagonists on sucrose and sucrose-ethanol reinforced responding. Pharmacol Biochem Behav 1994;48:141-50.
67. 67. Pfeffer AO, Samson HH. Oral ethanol reinforcement: Interactive effects of amphetamine, pimozide and food-restriction. Alcohol Drug Res 1985; 6:37-48.
68. 68. Pfeffer AO, Samson HH. Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session length. Drug Alcohol Depend 1986;17:47-55.
69. 69. Pfeffer AO, Samson HH. Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharamacol Biochem Behav 1988; 29:343-50.
70. 70. Grandy DK, Litt M, Allen L et al. The human dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989;45:778-85.
71. 2 dopamine receptor. Proc Natl Acad Sci USA 1989b;86:9762-6.
72. 2 receptor gene. Genomics 1991;10: 527-30.
73. 2 receptor gene in alcoholism. JAMA 1990;263:2055-60.
74. 2 receptor gene and alcoholism. JAMA 1990;264:3156-60.
75. 2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991;266:1801-7.
76. 2 receptor DNA polymorphism ruled out in 45 alcoholics. Am J Hum Genet 1991;49:203.
77. 77. Goldman D, Brown GL, Albaugh B et al. DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 1993;17: 199-204.
78. 2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 1992;86:351-7.
79. 2 receptor gene. Alcohol Clin Exp Res 1992;16:806-9.
80. 2 dopamine receptor gene and severe alcoholism. Biol Psychiatry 1992;31:285-90.
81. 2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 1994;19: 12-20.
82. 82. Sander T, Ladehoff M, Samochowiec J, Finckh U, Rommelspacher H, Schmidt LG. Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol Clin Exp Res 1999;23:578-81.
83. 83. Lee JF, Lu RB, Ko HC et al. No association between DRD2 locus and alcoholism after controlling the ADH and ALDH genotypes in Chinese Han population. Alcohol Clin Exp Res 1999; 23:592-9.
84. 2 receptor gene in samples of female and male alcoholics. Am J Med Genet: Neuropsychiatr Genet 1995;60:267-71.
85. 2 dopamine receptor locus: studies of association and linkage. Arch Gen Psychiatry 1991;48:655-63.
86. 2 receptor and alcoholism: a meta-analysis. Am J Med Genet: Neuropsychiatr Genet 1993;48:78-82.
87. 2 dopamine receptor locus in heavy drinking and alcoholism. Br J Psychiatry 1996;169:243-8.
88. 88. Reich T, Edenberg HJ, Goate A et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet: Neuropsychiatr Genet 1998;81:207-15.
89. 89. Edenberg HJ, Faroud T, Koller DL et al. A family-based analysis of association of the dopamine D2 receptor (DRD2) with alcoholism. Alcohol Clin Exp Res 1998;22:505-11.
90. 90. Curtis D, Zhao JH, Sham PC. Comparison of GENEHUNTER and MFLINK analysis of COGA linkage data. Genetic Epidemiol, (in press).
91. 91. Hill SY, Zezza N, Wipprecht G, Xu J, Neiswanger K. Linkage studies of D2 and D4 receptor genes and alcoholism. Am J Med Genet: Neuropsychiatr Genet, (In Press).
92. 92. Hill SY. Alternative strategies for uncovering genes contributing to alcoholism risk: unpredictable findings in a genetic wonderland. Proceedings of a UCLA Conference on Molecular Genetics of Alcoholism and Other Addictive/ Compulsive Disorders. Alcohol 1998;16:53-9.
93. 93. Turner A, Lawrence J, Chen ACH, Cook C, Gurling H. Frequency of the A1/A2 alleles of the D2 dopamine receptor (DRD2) gene in a British, Caucasian control group screened to exclude alcoholism and heavy drinking. Addict Biol 1997; 2:207-13.
94. 94. Gejman PB, Ram A, Gelernter J et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia: analysis using denaturing gradient gel electrophoresis. JAMA 1994;271:204-8.
95. 95. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997;6: 577-82.
96. 96. Bedell MA, Jenkins NA, Copeland NG. Good genes in bad neighbourhoods. Nat Genet 1996; 12:229-32.
97. 97. Noble EP, Blum K. The dopamine D2 receptor gene and alcoholism. JAMA 1991;265:2667.
98. 98. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) Taq I A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7:479-84.
99. 99. Pohjalainen T, Rinne JO, Nagren K et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998;3:256-60.
100. 100. Van Tol HHM, Wu CM, Guan H et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992;358:149-52.
101. 101. Asghari V, Schools O, Van Kats S et al. Dopamine D4 receptor repeat: analysis of different native mutant forms of the human and rat genes. Mol Pharmacol 1994;4:364-73.
102. 102. Parsian A, Chakraverty S, Fisher L, Cloninger CR. No association between polymorphisms in the human dopamine D3 and D4 receptor genes and alcoholism. Am J Med Genet 1997;74: 281-5.
103. 103. Adamson MD, Kennedy J, Petronis A et al. DRD4 dopamine receptor genotype and CFS monoamine metabolites in Finnish alcoholics and controls. Am J Med Genet 1995;60:199-205.
104. 104. Chang FM, Ko HC, Lu RB, Pakstis AJ, Kidd KK. The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: six polymorphisms tested separately and as haplotypes. Biol Psychiatry 1997;41: 394-405.
105. 105. George SR, Cheng R, Nguyen T, Israel Y, O'Dowd BF. Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 1993;196:107-14.
106. 106. Kotler M, Cohen H, Segman R et al. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 1997;2:251-4.
107. 107. Muramatsu T, Higuchi S, Murayama M, Matsushita S, Hayashida M. Association between alcoholism and the dopamine D4 receptor gene. J Med Genet 1996;33:113-5.
108. 108. Cloninger CR, Sigvardsson S, Przybeck TR, Svrakic DM. Personality antecedents of alcoholism in a national area probability sample. Eur Arch Psychiatry Clin Neurosci 1995;245: 239-44.
109. 109. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet 1996;12:81-4.
110. 110. Ebstein RP, Novick O, Umansky R, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996;12:78-80.
111. 111. Pogue-Geile M, Ferrell R, Deka R, Debski T, Manuck S. Human novelty-seeking personality traits dopamine D4 receptor polymorphisms: a twin and genetic association study. Am J Med Genet 1998;81:44-8.
112. 112. Hill SY, Zezza N, Wipprecht G, Locke J, Neiswanger K. Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics. Am J Med Genet Neuropsychiatr Genet 1999;88:634-41.
113. 113. Lerman C, Caporaso N, Main D, et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 gene. Health Psychol 1998;17:56-62.
114. 114. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. Philadelphia: FA Davis;1971.
115. 115. Goodwin DW, Hill SY. Chronic effects of alcohol and other psychoactive drugs on intellect, learning and memory. In: Rankin JG, editor. Alcohol, drugs, and brain damage. Toronto: Addiction Research Foundation of Ontario; 1975, pp. 55-70.
116. 116. Pfefferbaum A, Horvath TB, Roth WT, Kopell BS. Event-related potential changes in chronic alcoholics. Electroencephalogr Clin Neurophysiol 1979;47:637-47.
117. 117. Begleiter H, Porjesz B, Bihari B, Kissin B. Event-related brain potentials in boys at risk for alcoholism. Science 1984;225:1493-6.
118. 118. Steinhauer SR, Hill SY, Zubin J. Event-related potentials in alcoholics and their first-degree relatives. Alcohol 1987;4:307-14.
119. 119. Lille F, Hazemann P, El Massioui F, Leservre N, Dally S. Effect of chronic alcohol intake and short-term abstinence on early sensory EPs and late "cognitive" ERPs. In: Johnson R, Rohrbaugh JW, Parasuraman R, editors. Current Trends in Event-Related Potential Research, Electroencephalogaphy and Clinical Neurophysiology. Amsterdam: Elsevier Science Publishers; 1987, 40(suppl):712-17.
120. 120. Hermanutz M, Cohen R, Sommer W. The effects of serial order in long sequences of auditory stimuli on event-related potentials. Psychophysiology 1981;18:415-23.
121. 121. Hill SY, Steinhauer SR, Locke J. Event-related potentials in alcoholic men, their high-risk male relatives and low-risk male controls. Alcohol Clin Exp Res 1995;19:567-76.
122. 122. Pfefferbaum A, Ford JM, White PM, Mathalon D. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Alcohol Clin Exp Res 1991;15: 839-50.
123. 123. Porjesz B, Begleiter H, Bihari B, Kissin B. Event-related brain potentials to high incentive stimuli in abstinent alcoholics. Alcohol 1987;4:283-7.
124. 124. Porjesz B, Begleiter H, Bihari B, Kissin B. The N2 component of the event-related brain potential in abstinent alcoholics. Electroencephalogr Clin Neurophysiol 1987;66:121-31.
125. 125. Hill SY, Steinhauer SR. Event-related potentials in women at risk for alcoholism. Alcohol 1993;10: 349-54.
126. 126. Hill SY, Locke J, Steinhauer S. Absence of visual and auditory P300 reduction in non-depressed male and female alcoholics. Biol Psychiatry 1999;46:982-9.
127. 127. Hill SY, Shen S, Locke J, et al. Developmental delay in P300 production in children at high risk for developing alcohol-related disorders. Biol Psychiatry 1999;46:970-81.
128. 128. Whipple S, Parker ES, Noble EP. An atypical neurocognitive profile in alcoholic fathers and their sons. J Stud Alcohol 1988;49:240-44.
129. 129. Hill SY, Steinhauer SR, Park J, Zubin J. Event-related potential characteristics in children of alcoholics from high density families. Alcohol Clin Exp Res 1990;14:6-16 (reprinted in Ann Rev Addict Res Treatment 1992 177-92).
130. 130. Steinhauer SR, Hill SY. Auditory event-related potentials in children at high risk for alcoholism. J Stud Alcohol 1993;54:408-21.
131. 131. Hill SY, Steinhauer SR. Assessment of pre-pubertal and postpubertal boys and girls at risk for developing alcoholism with P300 from a visual discrimination task. J Stud Alcohol 1993;54: 350-8.
132. 132. Berman SM, Whipple SC, Fitch RJ, Noble EP. P300 in young boys as a predictor of adolescent substance use. Alcohol 1993;10:69-76.
133. 133. Howard L, Polich J. P300 latency and memory span development. Devel Psychol 1985;21:283-9.
134. 134. Courchesne E. Cognitive components of the event-related brain potential: changes associated with development. In: Gaillard AWK, Ritter W, editors. Tutorials in ERP research: endogenous components. Amsterdam: Eisevier Science Publishers; 1983, pp. 329-344.
135. 135. Johnson R Jr. Auditory and visual P300s in temporal lobectomy patients: evidence for modality-dependent generators. Psychophysiology 1989;26:633-50.
136. 136. Johnson R Jr. Developmental evidence for modality-dependent P300 generators: a normative study. Psychophysiology 1989;26:651-67.
137. 137. Hill SY, Steinhauer SR, Lowers L, Locke J. Eight year follow-up of P300 and clinical outcome in children from high-risk for alcoholism families. Biol Psychiatry 1995;37:823-7.
138. 138. Bock F. Pupillary dilation and vertex evoked potential similarity in monozygotic and dizygotic twins and siblings. Unpublished doctoral dissertation, City University of New York, 1976.
139. 139. Surwillo WW. Cortical evoked potentials in monozygotic twins and unrelated subjects: comparisons of exogenous and endogenous components. Behav Genet 1980;10:201-9.
140. 140. Aston CE, Hill SY. A segregation analysis of the P300 component of the event-related brain potential. Am J Hum Genet 1990;47(suppl):a127.
141. 141. Hill SY, Yuan H, Locke J. Path analysis of P300 amplitude of individuals from families at high and low risk for developing alcoholism. Biol Psychiatry 1999;45:346-59.
142. 142. O'Connor S, Morzorrati S, Christian JC, Li T-K. Heritable features of the auditory oddball event-related potential: peaks, latencies, morphology and topography. Electroencephalogr Clin Neurophysiol 1994;92:115-25.
143. 143. van Beijsterveldt CEM. The genetics of electrophysiological indices of brain activity: an EEG study in adolescent twins. University of Amsterdam, 1996.
144. 144. Hill SY, Locke J, Zezza N, Kaplan B, Neiswanger K, Steinhauer S, Wipprecht G, Xu J. Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry 1998;43:40-51.
145. 145. Schuckit MA. A clinical model of genetic influences in alcohol dependence. J Stud Alcohol 1994;55:5-17.
146. 146. Volavka J, Czobor P, Goodwin D, et al. The electroencephalogram after alcohol administration in high-risk men and the development of alcohol use disorders 10 years later. Arch Gen Psychiatry 1996;53:258-63.
147. 147. Lukas SE, Mendelson JH, Benedikt RA, Jones B. EEG alpha activity increases during transient episodes of ethanol-induced eurphoria. Pharmacol Biochem Behav 1986;25:889-95.
148. 148. Ehlers C, Wall T, Schuckit M. EEG spectral characteristics following ethanol administration in young men. Electroencephalogr Clin Neurophysiol 1989;73:179-87.
149. 149. Ehlers C, Schuckit M. Evaluation of EEG alpha activity in sons of alcoholics. Neuropsychopharmacology 1991;4:199-205.
150. 150. Cohen H, Porjesz B, Begleiter H. Ethanol-induced alterations in electroencephalographic activity in adult males. Neuropsychopharmacology 1993;8:365-70.
151. 151. Gabrielli WF, Mednick SA, Volavka J, Pollock VE, Schulsinger F, Itil TM. Electroencephalograms in children of alcoholic fathers. Psychophysiology 1982;19:404-7.
152. 152. Ehlers C, Schuckit M. EEG fast frequency activity in the sons of alcoholics. Biol Psychiatry 1990;27:631-41.
153. 153. Cohen H, Porjesz B, Begleiter H. The effects of ethanol on EEG activity in males at risk for alcoholism. Electroencephalogr Clin Neurophysiol 1993;86:368-76.
154. 154. Bauer L, Hesselbrock V. EEG, autonomic and subjective correlates of the risk for alcoholism. J Stud Alcohol 1993;54:577-89.
155. 155. Schuckit MA. Biological phenotypes associated with individuals at high risk for developing alcohol-related disorders. Part 2. Addict Biol 2000;5:23-36.